Skip to main content
Swing Capital

Albert David Ltd

NSE: ALBERTDAVD BSE: 524075Pharma

Incorporated in 1938, Albert David Ltd is in the business of manufacturing pharmaceutical products[1]

₹708
52W: ₹580 — ₹959
PE 0 · Book ₹686 · +3% vs book
Market Cap₹404 Cr
Stock P/E—Price to Earnings
ROCE0.77%Return on Capital
ROE0.38%Return on Equity
Div. Yield0.72%Face Value ₹10

Strengths

  • +Company is almost debt free.
  • +Stock is trading at 1.03 times its book value

Weaknesses

  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of 6.25% over past five years.
  • −Company has a low return on equity of 8.07% over last 3 years.
  • −Earnings include an other income of Rs.7.45 Cr.
  • −Working capital days have increased from 80.3 days to 247 days

Shareholding Pattern

Promoters62.23%
FIIs0.58%
DIIs1.65%
Public35.52%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters62.13%62.13%62.13%62.23%▲0.162.23%62.23%62.23%62.23%
FIIs0.8%0.88%▲0.10.86%▼0.01%▲0.10.84%▼0.20.6%▼0.20.6%0.58%▼0.0
DIIs1.67%1.63%▼0.01.63%1.64%▲0.01.65%▲0.01.65%1.65%1.65%
Public35.41%35.36%▼0.035.39%▲0.035.12%▼0.335.27%▲0.235.5%▲0.235.51%▲0.035.52%▲0.0

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales88898998837571879086
Expenses80798892828081857983
Operating Profit810161-5-113113
OPM %9%11%1%6%1%-6%-15%3%12%3%
Net Profit19131918-9-108-315-21
EPS ₹32.822.6233.0131.66-16.45-18.113.91-5.7826.81-37.55

AI Insights

Revenue Trend

Mar 2026 revenue at ₹334Cr, down 3.2% YoY. OPM at 2%.

Debt Position

Borrowings at ₹30Cr. Debt-to-equity ratio: 0.08x. Healthy balance sheet.

Capex Cycle

CWIP at ₹21Cr (21% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 1.65% (-0.65pp change). FIIs: 0.58% (-0.07pp change). Promoters hold 62.23%.

Margin & Efficiency

ROCE declining from 18% (Mar 2015) to 1% (Mar 2026). Working capital days: 247.

Recent Announcements